C. Herbst

SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer

Caitlyn A. Miller, R. Pai, D. Chang, 2019, Modern Pathology.

Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease–associated Colorectal Dysplasia and Adenocarcinoma

Caitlyn A. Miller, R. Pai, D. Hartman, 2019, The American journal of surgical pathology.

Prognostic significance of histologically detected lymph node micrometastases of sizes between 0.2 and 2 mm in colorectal cancer

A. Probst, T. Schaller, C. Cacchi, 2013, International Journal of Colorectal Disease.

Comparison of PD‐L1 immunohistochemistry assays and response to PD‐1/L1 inhibitors in advanced non‐small‐cell lung cancer in clinical practice

S. Dacic, B. Kurland, C. Herbst, 2018, Histopathology.

Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.

Caitlyn A. Miller, M. Regueiro, R. Pai, 2018, Inflammatory bowel diseases.